Phase I study of pazopanib and vorinostat: a therapeutic...

Annals of Oncology 2015 / 05 Vol. 26; Iss. 5

Phase I study of pazopanib and vorinostat: a therapeutic approach for inhibiting mutant p53-mediated angiogenesis and facilitating mutant p53 degradation

Fu, S., Hou, M. M., Naing, A., Janku, F., Hess, K., Zinner, R., Subbiah, V., Hong, D., Wheler, J., Piha-Paul, S., Tsimberidou, A., Karp, D., Araujo, D., Kee, B., Hwu, P., Wolff, R., Kurzrock, R., Meri
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
26
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdv066
Date:
May, 2015
File:
PDF, 183 KB
english, 2015
Conversion to is in progress
Conversion to is failed